AA

Adarsh Anand

Active Director Director DIN 10726545
DIN 10726545 First appointment Jul 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jul 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Adarsh Anand

Data last updated:

Adarsh Anand is a Director at Tirtham Connect Private Limited (since 2026) and Director at Lumecine Drugs Private Limited (since 2024).

DIN 10726545
Primary Designation Director
First Appointment 31 Jul 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Tirtham Connect Private Limited U79120BR2026PTC088417
Director26 Sep 20262026Active
Lumecine Drugs Private Limited U47721DL2024PTC434886
Director31 Jul 20242024Active

Board colleagues of Adarsh Anand

Directorship timeline

Open interactive timeline →
Lumecine Drugs Private Limited
Tirtham Connect Private Limited
Premium access

Shareholding and investment profile for Adarsh Anand

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Adarsh Anand

Adarsh Anand currently holds 2 directorships: Tirtham Connect Private Limited (Director, since 26 Sep 2026); Lumecine Drugs Private Limited (Director, since 31 Jul 2024).

Adarsh Anand was first appointed on 31 Jul 2024 as Director at Lumecine Drugs Private Limited. The most recent appointment on record is 26 Sep 2026 at Tirtham Connect Private Limited.

The current boards of Adarsh Anand's companies include Rekha Kumari (Tirtham Connect Private Limited), Vivek Vaibhav (Lumecine Drugs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available